Champions Oncology, Inc. Common Stock (CSBR)
Since Sep 13, 2021, Champions Oncology, Inc. Common Stock (CSBR) has reported earnings 14 times. On average the shares move ±4.50% post-earnings, with a positive reaction 64.3% of the time. Its largest post-earnings gain was +10.7% (Mar 15, 2022) and its largest decline was -10.19% (Dec 11, 2024). The next earnings report is predicted for 2026-09-11 (high confidence).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
14
Avg Abs. Movement
±4.50%
Positive %
64.3%
Negative %
35.7%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | ☽ POST | $5.93 | $5.93 | $5.93 | 0 | +0% | open_in_new |
| Dec 15, 2025 | ☽ POST | $7.18 | $7.54 | $7.14 | 1,070 | -1.26% | open_in_new |
| Sep 15, 2025 | ☽ POST | $7.62 | $8.59 | $8.11 | 1,687 | +0% | open_in_new |
| Mar 11, 2025 | ☽ POST | $9.12 | $9.12 | $8.90 | 278 | +2.81% | open_in_new |
| Dec 11, 2024 | ☽ POST | $5.62 | $5.79 | $5.79 | 2,473 | -10.19% | open_in_new |
| Sep 11, 2024 | ☽ POST | $4.08 | $4.08 | $4.08 | 179 | +9.31% | open_in_new |
| Mar 12, 2024 | ☽ POST | $5.92 | $5.92 | $5.92 | 0 | -8.95% | open_in_new |
| Dec 12, 2023 | ☽ POST | $4.82 | $4.82 | $4.82 | 321 | +0% | open_in_new |
| Sep 13, 2023 | ☽ POST | $6.57 | $6.57 | $6.57 | 0 | +0% | open_in_new |
| Mar 15, 2023 | ☽ POST | $4.30 | $4.30 | $4.30 | 245 | +5.35% | open_in_new |
| Dec 13, 2022 | ☽ POST | $6.58 | $6.58 | $6.58 | 100 | -10.03% | open_in_new |
| Sep 08, 2022 | ☽ POST | $7.21 | $7.21 | $7.21 | 0 | +3.95% | open_in_new |
| Mar 15, 2022 | ☽ POST | $7.66 | $7.66 | $7.66 | 261 | +10.7% | open_in_new |
| Sep 13, 2021 | ☽ POST | $9.88 | $10.11 | $10.09 | 800 | -0.45% | open_in_new |
Earnings Count
14
Total earnings in dataset
Avg Abs. Movement
±4.50%
Avg % price change on earnings
Frequently asked about CSBR earnings
When does Champions Oncology, Inc. Common Stock report earnings next? expand_more
Champions Oncology, Inc. Common Stock (CSBR)'s next earnings date is predicted (high confidence) for 2026-09-11. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CSBR stock move after earnings? expand_more
Over 14 reports, CSBR has moved an average of ±4.50% the session after earnings, closing higher 64.3% of the time.
What was CSBR's biggest post-earnings move? expand_more
CSBR's largest post-earnings gain on record was +10.7% on Mar 15, 2022, and its largest decline was -10.19% on Dec 11, 2024.
Where can I find Champions Oncology, Inc. Common Stock's SEC filings? expand_more
All of Champions Oncology, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right